SCHEMBL1664249

SCHEMBL1664249

Cc1[nH]cc(C(=O)Nc2ccc(Nc3ccc(Nc4ccc(N5CCC(O)CC5)cc4)cc3)cc2)c1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.46
RAB9A P51151 7/20 0.46
ALDH1A1 P00352 5/20 0.46
SMN1; SMN2 Q16637 5/20 0.46
MAPT P10636 4/20 0.46
GAA P10253 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
MAPK1 P28482 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
KMT2A Q03164 3/20 0.45
KDM4E B2RXH2 2/20 0.45
MCL1 Q07820 2/20 0.45
GLA P06280 1/20 0.45
MEN1 O00255 2/20 0.44
MT-CO2 P00403 5/20 0.44
PDE7A Q13946 1/20 0.43
HPGDS O60760 1/20 0.43
LMNA P02545 1/20 0.43
USP2 O75604 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1664252 0.96 MAPT (0.50) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL1667499 0.85 RAB9A (0.49) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL1664638 0.84 EGFR (0.44) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL1664033 0.83 MAPT (0.46) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL1667500 0.81 RAB9A (0.52) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL1664639 0.81 RAB9A (0.50) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL1665248 0.81 NPC1 (0.51) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL1664934 0.80 HRH3 (0.55) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL1664038 0.80 MAPT (0.49) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL6126340 0.79 PDE7A (0.44) NPC1RAB9AALDH1A1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2642994-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS Ligand Pharmaceuticals Incorporated (US) 2013-10-02 EP disclosed
EP-2488486-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES Ligand Pharmaceuticals Inc. (US) 2012-08-22 EP disclosed
WO-2012068406-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS LIGAND PHARMACEUTICALS INCORPORATED (US) 2012-05-24 WO disclosed
WO-2011046954-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES LIGAND PHARMACEUTICALS INC. (US) 2011-04-21 WO disclosed